Skip to Main Content

Paper Details

High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better.
Mayo Clin Proc
7
2021
ASCVD, Patients, Statins, atherosclerotic cardiovascular disease, bempedoic, bile acid, cholesterol, coronary, diabetes, ezetimibe, hypercholesterolemia, low-density lipoprotein cholesterol, patient, patients, proprotein convertase, statin, statins, subtilisin, subtilisin/kexin type 9
Author NameAffiliation
Scott M GrundyUniversity of Texas Southwestern Medical Center and VA Medical Center
Neil J StoneNorthwestern University Feinberg School of Medicine
Paul A HeidenreichStanford University
Donald M Lloyd-JonesNorthwestern University Feinberg School of Medicine
Salim S ViraniBaylor College of Medicine and Michael E. DeBakey VA Medical Center
  • 1 - 5

Datasets

Release 1.2